The cannabinoid metabolising enzyme fatty acid amide hydrolase is aberrantly expressed in recurrent miscarriage

被引：0
作者：
Chamley, L. W.
Bhalla, A.
Stone, P. R.
Kearn, C. S.
Glass, M.
机构：
[1] Univ Auckland, Dept Obstet & Gynaecol, FMHS, Auckland 1, New Zealand
[2] Univ Auckland, Dept Pharmacol, FMHS, Auckland 1, New Zealand
[3] Univ Washington, Dept Anesthesiol, Seattle, WA 98195 USA
来源：
PLACENTA | 2007年 / 28卷 / 8-9期
关键词：
D O I：
暂无
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：A42 / A42
页数：1
相关论文
共 50 条
  • [31] Fatty Acid Amide Hydrolase and Cannabinoid Receptor Type 1 Genes Regulation is Modulated by Social Isolation in Rats
    Antonio Girella
    Martina Di Bartolomeo
    Enrico Dainese
    Valeria Buzzelli
    Viviana Trezza
    Claudio D’Addario
    Neurochemical Research, 2024, 49 : 1278 - 1290
  • [32] The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition
    Scherma, Maria
    Medalie, Julie
    Fratta, Walter
    Vadivel, Subramanian K.
    Makriyannis, Alexandros
    Piomelli, Daniele
    Mikics, Eva
    Haller, Jozsef
    Yasar, Sevil
    Tanda, Gianluigi
    Goldberg, Steven R.
    NEUROPHARMACOLOGY, 2008, 54 (01) : 129 - 140
  • [33] Inhibition of fatty acid amide hydrolase, a key endocannabinoid metabolizing enzyme, by analogues of ibuprofen and indomethacin
    Holt, Sandra
    Paylor, Ben
    Boldrup, Linda
    Alajakku, Kirsi
    Vandevoorde, Severine
    Sundstrom, Anna
    Cocco, Maria Teresa
    Onnis, Valentina
    Fowler, Christopher J.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2007, 565 (1-3) : 26 - 36
  • [34] Thiadiazolopiperazinyl ureas as inhibitors of fatty acid amide hydrolase
    Keith, John M.
    Apodaca, Richard
    Xiao, Wei
    Seierstad, Mark
    Pattabiraman, Kanaka
    Wu, Jiejun
    Webb, Michael
    Karbarz, Mark J.
    Brown, Sean
    Wilson, Sandy
    Scott, Brian
    Tham, Chui-Se
    Luo, Lin
    Palmer, James
    Wennerholm, Michelle
    Chaplan, Sandra
    Breitenbucher, J. Guy
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (17) : 4838 - 4843
  • [35] Modulation of angiogenesis by the fatty acid amide hydrolase (FAAH)
    Koester, S.
    Rieck, S.
    Vosen, S.
    Matthey, M.
    Meyer, J.
    Schmitz-Valckenberg, S.
    Fleischmann, B.
    Wenzel, D.
    ACTA PHYSIOLOGICA, 2014, 210 : 120 - 120
  • [36] Fatty Acid Amide Hydrolase: An Integrative Clinical Perspective
    Santoso, Anugrah D.
    De Ridder, Dirk
    CANNABIS AND CANNABINOID RESEARCH, 2023, 8 (01) : 56 - 76
  • [37] Fatty Acid Amide Hydrolase: Past, Present and Future
    Piomelli, Daniele
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S70 - S70
  • [38] Novel propanamides as fatty acid amide hydrolase inhibitors
    Deplano, Alessandro
    Morgillo, Carmine Marco
    Demurtas, Monica
    Bjorklund, Emmelie
    Cipriano, Mariateresa
    Svensson, Mona
    Hashemian, Sanaz
    Smaldone, Giovanni
    Pedone, Emilia
    Javier Luque, F.
    Cabiddu, Maria G.
    Novellino, Ettore
    Fowler, Christopher J.
    Catalanotti, Bruno
    Onnis, Valentina
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 136 : 523 - 542
  • [39] Fatty Acid Amide Hydrolase Inhibitors - Progress and Potential
    Khanna, Ish K.
    Alexander, Christopher W.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2011, 10 (05) : 545 - 558
  • [40] Inhibition of Fatty Acid Amide Hydrolase (FAAH) by Macamides
    M. Alasmari
    M. Bӧhlke
    C. Kelley
    T. Maher
    A. Pino-Figueroa
    Molecular Neurobiology, 2019, 56 : 1770 - 1781
12345